Futurmed
VC Fund
Budapest, Hungary
Futurmed is a med asset management company.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cytocast
|
Cytocast is leveraging the integration of bioinformatics databases and patient data within a computer model to create a groundbreaking cell simulation software. This software holds the potential to revolutionize patient treatment, significantly impact the drug development process, and enable the identification of optimal therapeutic options. Thecomprehensive cell model that forms the basis of the technology combines molecular knowledge of how healthy cells function to understand the effects of perturbations caused by diseases and predict how drugs can modify cellular health. | $1.8M / Pre-Seed / May 15, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
FAQ
When did Futurmed last invest?
The most recent investment recorded for Futurmed closed in May 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
